In Brief This Week: Bio-Rad Laboratories; TGen, Van Andel Research Institute; Infosys, Elan; Dotmatix, Boehringer Ingelheim | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories has completed its offer to exchange up to $300 million aggregate principal amount of its 8 percent Senior Subordinated Notes due 2016 for any and all of its outstanding 8 percent Senior Subordinated Notes due 2016 that were issued in a private placement. All of the notes were tendered before the deadline yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.